🎁
DIWALI SPECIAL

20% OFF + 1-Yr NT Prime FREE !

Use
00h : 00m : 00s
Claim Offer →
logo

JUBLINGREA vs NOCIL: Stock Comparison

JUBILANT INGREVIA vs NOCILUpdated 30 Oct 26, 9:25 AM ISTNSE & company filings

JUBILANT INGREVIA is the larger company by market capitalisation. JUBILANT INGREVIA shows a lower P/E, a higher ROE and faster revenue growth, while NOCIL shows a higher dividend yield and lower leverage. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

JUBLINGREA leads 8; NOCIL leads 3 of 13

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

JUBLINGREANOCIL

Valuation lens

What price are you paying?

Market CapContext only
₹9,038 Cr
₹2,476 Cr
P/E RatioJUBLINGREA has the lower reading
25.58x ✓
36.78x
P/B RatioNOCIL has the lower reading
2.7x
1.37x ✓
EPSJUBLINGREA has the higher reading
₹6.64 ✓
₹1.66
Book ValueContext only
₹196.27
₹106.18
Dividend YieldNOCIL has the higher reading
0.89%
1.03% ✓

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
JUBLINGREA is the larger company
₹9,038 Cr vs ₹2,476 Cr
P/E Ratio
JUBLINGREA has a lower P/E
25.58x vs 36.78x
P/B Ratio
NOCIL has a lower P/B
1.37x vs 2.7x
EPS
JUBLINGREA has higher earnings per share
₹6.64 vs ₹1.66
Dividend Yield
NOCIL has a higher dividend yield
1.03% vs 0.89%
Revenue Growth (TTM YoY)
JUBLINGREA has faster revenue growth
12.1% vs -2.8%
EPS Growth (TTM YoY)
JUBLINGREA has faster EPS growth
16.1% vs -19.2%
ROE
JUBLINGREA has a higher ROE
10.15% vs 3.14%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricJUBLINGREANOCIL
SectorChemicalsChemicals
IndustrySpecialty ChemicalsSpecialty Chemicals

Price

MetricJUBLINGREANOCIL
Live Price₹556.5₹142.74
Day Change-2%-1.8%
Volume38,6854.26 L
52-Week High₹795₹211.2
52-Week Low₹537.3₹125.31
Distance from 52W High-30%-32.41%

Valuation

MetricJUBLINGREANOCIL
Market Cap₹9,038 Cr₹2,476 Cr
P/E Ratio25.58x36.78x
P/B Ratio2.7x1.37x
EPS₹6.64₹1.66
Book Value₹196.27₹106.18
Dividend Yield0.89%1.03%

Growth

MetricJUBLINGREANOCIL
Revenue Growth (TTM YoY)12.1%-2.8%
EPS Growth (TTM YoY)16.1%-19.2%
Qtr Sales Growth0%0%
Qtr Profit Growth0%0%

Profitability & Leverage

MetricJUBLINGREANOCIL
ROE10.15%3.14%
ROCE10.19%3.61%
Net Margin6.61%4.86%
Operating Margin9.63%5.94%
Debt to Equity0.28x0x

Shareholding

As of Sep 2026 • change vs previous quarter
MetricJUBLINGREANOCIL
Promoter Holding41.7%33.76%
FII Holding6.94%▲ 0.45 pp5.28%▲ 0.5 pp
DII Holding25.17%▲ 0.19 pp6.96%▼ 0.51 pp
Public Holding21.69%▼ 0.6 pp53.99%▲ 0.01 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: JUBILANT INGREVIA and NOCIL.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.